THOMAS MCKEAN: Open Payments
NPI 1841359486 · HICKORY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,936 in 141 payments from 20 companies in 2025. Trend: 2023 $2,624 · 2024 $2,671 · 2025 $2,936
Food & beverage: $2,936
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 21 | $428 |
| Alkermes, Inc. | 19 | $390 |
| Neurocrine BioSciences, Inc. | 14 | $344 |
| Vanda Pharmaceuticals Inc. | 12 | $293 |
| Otsuka America Pharmaceutical, Inc. | 12 | $283 |
| E.R. Squibb & Sons, L.L.C. | 16 | $262 |
| Axsome Therapeutics, Inc. | 11 | $224 |
| Teva Pharmaceuticals USA, Inc. | 9 | $177 |
| Bausch Health US, LLC | 6 | $140 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $74 |
Products named: CAPLYTA, ARISTADA, INGREZZA, FANAPT, REXULTI, COBENFY, Auvelity, APLENZIN.
Industry payments across NC — which companies pay providers there.
